Devdatt Kurdikar - 31 Mar 2025 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
Director
Signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Devdatt Kurdikar (power of attorney previously filed)
Issuer symbol
ZBH
Transactions as of
31 Mar 2025
Net transactions value
$0
Form type
4
Filing time
02 Apr 2025, 16:03:37 UTC
Previous filing
03 Jan 2025
Next filing
08 Apr 2025

Key filing fact

Devdatt Kurdikar filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 02 Apr 2025.

Key facts

  • This page summarizes Devdatt Kurdikar's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 02 Apr 2025, 16:03.

Change

  • Previous filing in this sequence was filed on 03 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

ZBH transaction Derivative

Phantom Stock Units

Award

Transaction value
$0
Shares
+122
Change %
+32%
Price
$0.000000
Shares after
508
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
122
Exercise price
$112.51
Footnotes
F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3 The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4 Includes 0.556 phantom stock units accrued January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .